Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
- 15 January 2001
- journal article
- clinical trial
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 62 (1) , 12-18
- https://doi.org/10.4088/jcp.v62n0104
Abstract
There is a clear need for effective, well-tolerated intramuscular (i.m.) agents for the acute control of agitated psychotic patients. Currently used agents, including conventional antipsychotics and/or benzodiazepines, may be associated with distressing side effects such as extrapyramidal side effects and excessive sedation.Keywords
This publication has 0 references indexed in Scilit: